Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

ABSTRACT: RATIONALE: Vaccines made from a person’s cancer proteins may help the body build an effective immune response to kill cancer cells. Colony-stimulating factors, such as GM-CSF, may increase the number of immune cells found in bone marrow or peripheral blood. Giving vaccine therapy together with GM-CSF may make a stronger immune response and kill more cancer cells. PURPOSE: This phase II trial is studying the side effects and how well giving vaccine therapy together with GM-CSF works in treating patients with CNS lymphoma.

DISEASE(S): Lymphoproliferative Disorders,Central Nervous System Neoplasms,Lymphoproliferative Disorder,Nervous System Neoplasms,Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Brain And Central Nervous System Tumors,Intestinal Neoplasms,Lymphoma

PROVIDER: 2051068 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR